Leaders In Healthcare

JUNE 2019

A special presentation complimentary with Forbes India. Not for Sale.

CONTENTS5 Nat Health

6 Apollo Hospitals

8 Aster DM Healthcare

10 Dr. L H Hiranandani Hospital

12 Sir Ganga Ram Hospital

14 Manipal Education & Medical Group

16 Orchids Breast Health Centre

18 Neurogen Brain & Spine Institute

20 Jupiter Hospital

22 Becton Dickinson India Pvt Ltd

24 Bosch

26 Dr. Pradeep V Mahajan (StemRx)

28 Care24

30 Suburban Diagnostics

ORIGIN MEDIA SOLUTIONS PVT LTD

105, ‘B’ Wing , Labh Ashish Building, Old Police Lane, Andheri (East), Mumbai 400069Manish Sharma – 9082746179manish@originmediasolution.comSandeep Sharma – 7977059538sandeep@originmediasolution.com

Marketing:

Shagufta Khan

Jitendra Gujar

Siddhi Patel

Advertising Sales:

Preeti Sahni

Mona Parate

Priyanka Nalavade

Janki Modi

Riti Menghani

Arijit Nandy

Daksha Solanky

Distribution:

Subhadra Bose

Kaushal Pillai

Advertising Operation:

Chaitali Karia

Smita Suvarna

Krishna Gupta

Prashant Rane

Forbes India Marquee, a marketing initiative, is a complimentary

supplement for Forbes India readers.

Design and Layout done by:

Disclaimer: This book is a special marketing initiative of Origin Media

Solutions in partnership with Forbes India Marquee. While Origin Media

Solution has taken utmost care to issue error free knowledge in the public

domain, readers are advised to independently verify the claims made in

the book. Origin Media Solution is not equipped to verify the claims made

in the book and readers discreet is therefore recommended.

4 FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE

3,19,780 people, indicating bright career

opportunities. In fact, the contributions

of internationally credible education and

training centres and programmes such as

Hiranandani Orthopaedic Medical Education

and Manipal Education and Medical Group

are unparalleled.

This can be attributed to a number

of growth drivers such as infrastructural

investment, which, according to Invest

India, is expected to be $200 billion by 2024.

Improved life expectancy, as well as rising

disposable income and increased insurance

penetration, are other factors. Reduced

costs due to greater efficiency facilitated

by technology particularly robotic process

automation and rise in health and wellness

centres are also contributing to the growth

of India’s shining healthcare industry. Robotic

and computer assisted therapy is also used at

rehabilitation centres such as Jupiter Hospital’s

neuro-rehabilitation centre, which is also

home to Asia’s first aquatic rehabilitation pool.

With the government’s prerogative to roll-

out the world’s largest government-funded

healthcare programme, the importance of

providing quality, affordable and accessible

healthcare will continue to be the key

parameter for economic success.

In this supplement, we profile

changemakers and trendsetters in Indian

healthcare. They highlight the latest

advancements in the sector and the

challenges that lie ahead, as well as share

their road maps for a promising future.

India’s Dynamic Healthcare SectorIndia has come a long way from the smallpox epidemic in 1974. Of course, there have been newer challenges such as the swine u of 1 and the ipah virus outbrea in erala in 1 but that only proves how advanced our medical research is.

According to Invest India, the healthcare information technology market is expected

to grow 1.5 times from the current $1billion by 2020. Medical technology plays an

important role not just in terms of diagnostics and surgical procedures but also support

functions such as R&D and medical informatics.

Smart HealthcareTelemedicine or telehealth is fast catching up. Video conferencing, for instance, saves time

and money. m-health (mobile health) and e-health are fast catching up too and there several

mobile applications for mental health, weight loss, chronic care management and more.

Applications that identify potential health threats and examine digital information also exist.

Telemonitoring technology has increased mobility, enabling doctors to monitor vital signs and

symptoms remotely.

In India, the home healthcare market size is roughly $4 billion with ancillary markets about

$20 billion. The concept of medical tourism is also flourishing and expected to grow to $9 billion

by 2020. Scientists have been able to examine diseases on a cellular level and produce antibodies

against them. Stem cell therapy has revolutionised the care of autistic patients, as well as those

suffering from strokes, spinal cord injuries, muscular dystrophy and cerebral palsy.

There are numerous surgeries which are being carried out without opening the body. Laser

operations, for instance. In fact, minimally-invasive surgeries such as transcatheter therapies are

allowing patients to spend less time in recovery.

The new technologies of today even allow doctors to find out an increasing amount

of detailed information about both, the progression and treatment of disease, and offer

personalised treatment based on a patient’s genes. The system of integrated patient clinics

has had a great impact where the patient meets with many specialists together. Before the

meeting, the doctors can access the patient’s detailed history.

A Promising Future The value of India’s healthcare sector may increase to $372 billion by 2022 according to Invest

India. By 2020, India is expected to rank among the top three healthcare markets in terms of

incremental growth. In 2017, the industry stood as the fourth largest employer, employing

In India, the home

healthcare market size is

roughly $4 billion with

ancillary markets about

$20 billion. The concept

of medical tourism is also

flourishing and expected to

grow to $9 billion by 2020.

FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE 5

NATHEALTH: Powered By A Critical Need

In celebration of our

7th anniversary, we

will recommit to our

vision in building a

better and healthier

India by unifying the

voice of the ecosystem

and harnessing its true

potential.

To solve this paradox is our most immediate

challenge. It will take our combined effort. It

will take our commitment and continuous

engagement. Most importantly, it will take a

spirit of collaboration and partnership from all

stakeholders.

Healthcare industry participants in India have

come together to work along with policy

makers to create an environment that will

power the next wave. NATHEALTH is the

genesis of this movement. It is the forum that

will facilitate the shift in mindset, delivery

and decision making. In celebration of our

7th anniversary, we will recommit to our

vision in building a better and healthier India

by unifying the voice of the ecosystem and

harnessing its true potential.

Indian healthcare is in a truly unique juncture at this point. At one end, we have taken giant

strides to establish ourselves as a highly skilled and efficient medical ecosystem with excellent

clinical outcomes driving a powerful value proposition. But this is counterbalanced by a massive

disease burden, tangible dichotomies in healthcare delivery and massive infrastructure crunch.

is the genesis of a movement to bring the healthcare ecosystem in one place. It is the forum that will facilitate the shift in mindset, delivery and decision ma ing.

www. nathealthindia.orgContact us at: secretariat@nathealth.co.in

6 FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE 7

Ms. Suneeta Reddy, Managing Director,Apollo Hospitals Enterprise Ltd.

Dr. Preetha Reddy,Vice Chairperson, Apollo Hospitals Enterprise Ltd.

6 FORBES INDIA MARQUEE . LEADERS

ratifies Apollo Hospitals’ position as the leader in Indian healthcare

industry.

Apollo Hospitals is today at the forefront of the Technological

Renaissance in healthcare. Leading from the front, Apollo Hospitals

has ensured that the best of medical advances and technology are

made available to the patients in India, making available world class

healthcare at a fraction of the cost as compared to other countries

across the globe.

Cardiovascular diseases and Cancer are the two main NCDs

responsible for premature mortality in India today, and along with

chronic respiratory disease and diabetes, the probability of dying

from these four NCDs is 26%! NCDs today account for 61% of total

deaths in India and with the vision and dedication to reduce these

numbers, Apollo Hospitals is the bulwark against the tsunami of Non-

communicable diseases (NCDs) that the country faces today.

Cardiovascular diseases including coronary heart disease, stroke,

and hypertension contribute to over 45% of all deaths from NCDs.

Heart problems can be diagnosed early, managed well and treated

completely in most cases and it is here that Apollo Hospitals has

redefined ‘Heart Care’ in the country.

Pioneering cardiac surgery with the repair of an Atrial Septal

defect in 1983, today, the Apollo Heart Institutes offer a multitude of

treatments and procedures in cardiology and cardiothoracic surgery

at centres across the country. Apollo Hospitals’ healing touch has

helped patients with an unmatched record of over 1,52,000 cardiac

and cardiothoracic surgeries, one of only 10 hospitals in the world to

achieve these volumes.

Apollo Hospitals’ journey in cardiac care has seen multiple firsts

including Coronary Artery Stenting for the first time in India, the first

keyhole multiple bypass surgery and the first heart transplant in India.

Today, Apollo Hospitals’ prowess in cardiac care is backed by the

largest cohort of cases treated with advanced cardiac interventional

methods. These include three key innovations – MitraClip, TAVI (Trans-

catheter Aortic Valve Implantation) or TAVR (Trans-catheter Aortic Valve

Replacement) and MICS CABG or MICAS (Minimally Invasive Coronary

Artery Bypass Surgery). Specialists in structural and interventional

cardiology at Apollo Hopsitals have successfully performed 6 MitraClip

procedures out of the 9 performed in India, over 85 TAVI/TAVRs with

Apollo Hospitals- Bulwark Against The NCD Tsunami!The state-of-the-art Apollo Proton Cancer Centre APCC in outh ast Asia rst of its ind opened earlier this year, rati es Apollo

Hospitals’ position as the leader in Indian healthcare industry.

Arenowned cardiologist known for his intuitive diagnostic

abilities, Dr. Prathap Reddy was just turning 50 when he

launched Apollo Hospitals and in the process revolutionised

healthcare in India. Thirty-six years later, with more than 32 million

people treated, the Apollo Hospitals group has become one of the

world’s leading centres for quaternary healthcare including cardiac

surgery, oncology, organ transplants (Heart, Lung, Liver, Pancreas,

Intestine and Kidney), bone marrow transplants, liver disease, joint

replacement and robotic surgery.

Today, Apollo Hospitals is renowned for delivering cutting-edge

healthcare embellished with a human touch at par with the best

centres in the world. The state-of-the-art Apollo Proton Cancer Centre

(APCC) in South East Asia – first of its kind – opened earlier this year,

excellent clinical outcomes and a nation-leading

1250+ MICS CABGs with superior outcomes at par

with international standards, at only half or one

third of the cost compared to global price matrix.

Cancer is the second leading cause of death

globally and according to the World health

Organization, 1 in 6 deaths globally in 2018 was

due to cancer. Apollo began its fight against cancer

in 1993 with a dedicated state-of-the-art facility for

cancer care in Chennai. Apollo has made significant

advances in treating this dreaded disease and has

been leading from the frontline in the war on cancer

by setting up South East Asia’s first proton therapy

centre for cancer, the Apollo Proton Cancer Centre

(APCC) launched earlier this year, which serves

over3.5 billion people across South East Asia. The

clinical advantages of proton therapy as compared

to conventional radiation therapy are many, with

more than 2,00,000 patients successfully treated

worldwide. Proton beam therapy takes the fight to

cancer with increased precision and greater dose

delivery at the precise site of the cancer, minimizing

damage to healthy tissue, better quality of life and

a higher cure rate. This ultimately results in better

results with fewer short and long-term side effects.

But even prior to the launch of the APCC, Apollo

Hospitals has always been quick to adopt new

technology to help advance treatment for cancer.

From the first Cyberknife Robotic Radio Surgery

System to the TrueBeam STx stereotatic radiosurgery

system, Apollo empowered its doctors to offer

patients with cancer, a non-invasive alternative

to traditional surgery. Cancer specialists at Apollo

Hospitals can use the most advanced TrueBeam

STx system, which is the fastest in treatment speed,

precision and simplicity to accurately target tumors

of the brain, spine, lung and other areas that are

typically difficult to treat surgically.

Apollo Cancer Institutes’ unique approach

to diagnosing, treating and monitoring cancer

powered by specialized expert organ-specific

tumor boards that discuss diagnostics and therapy

options to provide the most beneficial and effective treatment to thousands of patients.

As technology has evolved rapidly over the last two decades, Apollo Hospitals has

also been at the forefront in adopting Artificial Intelligence (AI) to bring a paradigm shift

to the practice of medicine with tools designed to equip doctors in the fight against

the rising burden of NCDs, especially cardiology, cancer and neurology. Apollo Hospitals’

Intelligent Platform – designed in collaboration with Microsoft – helps to predict

cardiovascular disease risk score in the Indian population. Doctors across the Apollo

network of hospitals are today leveraging this AI-powered API to predict risk of CVD and

drive preventive cardiac care across the country.

Combining Applied AI and clinical expertise, many other platforms are being

developed for other NCDs that include Adult diabetes care pathway, Hypertension

treatment and control pathway, cholesterol management in cardiovascular risk pathway,

and prevention of stroke and CVA. The future will see AI playing a major part at Apollo

Hospitals in prediction and monitoring of disease while empowering physicians with the

power of data to make superior clinical decisions.

Dr. Prathap C. ReddyFounder, Chairman Apollo Hospital Group

Ms. Sangita Reddy,Joint Managing Director,Apollo Hospitals Enterprise Ltd.

Ms. Shobana Kamineni, Executive Vice Chairperson, Apollo Hospitals Enterprise Ltd.

8 FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE 9

DM Healthcare’s India operations are often

leveraged for their expertise in advanced

tertiary and quaternary care, and each year

its multi-specialty hospitals in Kerala and

Bengaluru receive a significant number of

patients from international markets.

In India, Aster DM Healthcare is also being

recognised for clinical excellence and the

introduction of innovative medical solutions

that address patients’ needs. Recently, at

Aster CMI Hospital in Bengaluru, a 13-year

old patient from Mauritius was brought,

suffering from rarest of the rare Complement

Deficiency genetic disease, C1q deficiency

since the age of 2. She underwent a

successful bone marrow transplant for the

condition and became the first teen in Asia

suffering from this complex condition to

receive this particular treatment. Globally, less

than 10 such cases have been successfully

transplanted.

Aster Medcity Hospital is another example of

the company’s high quality and personalised

medical care commitment. A 670-bed

multi-specialty quaternary care facility with

10 dedicated Centres of Excellence, it is

the first quaternary care hospital in Kerala

to have achieved the coveted JCI (Joint

Commission International) Accreditation –

the gold standard in global healthcare and is

considered a focal destination for healthcare

tourism from across the world. Aster MIMS

Hospital in Calicut was declared a Centre for

Quality Promotion (CQP) by the Consortium

of Accredited Healthcare Organisations

and is known for performing successful

advanced medical procedures like renal

transplants using robotic surgical systems

Quality Healthcare made affordable and accessible in IndiaAs one of the top healthcare service providers in India, Aster DM Healthcare continues to push the boundaries of healthcare excellence.

The healthcare market is India is expected to reach US$ 372 billion by 2022, while the

hospitals industry is expected to grow at a CAGR of 16-17% to reach Rs. 8.66 trillion by

FY22. This growth will be primarily driven by rising incomes, better health awareness,

growing incidence of lifestyle diseases and improving access to health insurance. With the

government’s prerogative to roll-out the world’s largest government-funded healthcare

programme, the importance of providing quality healthcare that is affordable and accessible

will continue to be the key parameter for economic success.

At Aster DM Healthcare, the universal healthcare philosophy of Quality, Affordability and

Accessibility for all was ingrained in the company, since its inception in 1987 in the UAE. Starting

from a single clinic in Bur Dubai, to becoming a globally integrated healthcare conglomerate

with 24 hospitals, 114 clinics and 219 pharmacies across nine countries, Aster DM Healthcare

has over the last 15 years grown from strength to strength providing quality care through

its network of 12 hospitals and eight clinics in India. Today, it is the third largest healthcare

provider in India by market capex.

The company commenced its India operations in 2001 with the establishment of the Malabar

Institute of Medical Science in Calicut (Aster MIMS), Kerala, which offers end-to-end care

across primary, secondary, tertiary and quaternary healthcare. Within its global network, Aster

and transcatheter aortic valve implantations

(TAVI), which have set the benchmark for

clinical excellence in the region. Aster MIMS

Hospital in Kottakal, DM WIMS in Wayanand

and the recently introduced 300 bedded

Aster MIMS Hospital in Kannur are some of

the other facilities in Kerala. Apart from Kerala,

Aster Hospitals are located in 4 others states in

India: Aster CMI Hospital in Bengaluru (Aster

RV Hospital to be operational soon); Aster

Aadhar Hospital in Kolhapur, Maharashtra;

Aster Prime Hospital in Telengana; and

Ramesh Hospitals in Andhra Pradesh.

As part of its commitment to India, Aster DM

Healthcare listed its stocks on the Bombay

Stock Exchange in February 2018. A significant

proportion of the proceeds gathered from

the IPO are now being used to strengthen its

offerings in India. In addition, the company is

constantly striving to enhance the learning

opportunities for its doctors. Aster has been

recognised by the Royal College of Obstetrics

and Gynaecologists (RCOG) for its international

programme accreditation for Core Medical

Training (CMT). Aster Medcity in Kerala and

Aster Hospital at Mankhool in Dubai UAE will

be the second in the world after Iceland to

deliver CMT outside the UK. Aster Medcity has

also signed an MOU with the Thomas Jefferson

University, USA to provide its doctors with

access to global knowledge, research and best

practices. The first collaboration to be initiated

is a multi-organ transplant programme.

As one of the top healthcare service providers

in India, Aster DM Healthcare continues to

push the boundaries of healthcare excellence

and provide compassionate care to people

across geographies.

Q&A with Dr. Azad Moopen- Founder Chairman and Managing Director, Aster DM Healthcare

A single clinic in 1987, to a chain

of hospitals present in multiple

countries. Please share your inspiring

entrepreneurial journey till now.

When we started Aster DM Healthcare as

a single doctor clinic in Dubai in 1987, we

wanted to provide affordable quality healthcare

services to people. Over the last three decades,

our efforts have seen us expanding our offering

beyond Dubai, to other GCC countries and

India. We operate now in 9 countries with 24

hospitals, 114 Clinics and 219 Pharmacies.

We commenced our India operations in 2001 with the establishment of the Malabar

Institute of Medical Science (Aster MIMS) in Calicut, Kerala and currently we have 12

hospitals and 8 clinics in India with a total bed capacity of 4400. We see India as a growth

market and with this thought we listed our company in India in February 2018.

Aster DM Healthcare recently completed a year of listing in India. How has the

one year journey been? Also, what is your strategy and focus for Indian market?

We see India as a growth market. With 12 hospitals in India, we are now looking at

expanding our presence through organic growth and acquisitions. We would like to

further consolidate our presence in South and Western India. Our model is to have large

hospitals with 300-500 beds in major cities. If any opportunity comes up in the North

which is suited to our business model, then we can consider. We prefer asset-light model

where the land and building are either on long-term lease hold or O&M. We can also look

for inorganic growth through acquisitions if the valuations are reasonable.

Presently, 17% of our revenues come from India and our aim is to increase the figure to

25% revenue from India in the next few years. Considering the current demand for quality

healthcare, India is a focus market for us where we have 4,400 beds and have plans to take

it up to 6,000 beds through 3 hospitals which are in the pipeline: Bengaluru, Chennai and

Thiruvananthapuram. For this, we have plans to invest upto Rs750 crore by 2022.

You aim to be a global health service provider. What differentiates you from

other healthcare service providers?

We are different from other healthcare service providers as we provide complete

specialties of services from primary to quaternary care through the network of clinics,

hospitals and pharmacies. We do everything from primary consultation to cardiology

transplantations in our hospitals. Another differentiating feature is that we have 3

separate brands in GCC catering to the upper, middle and lower-income groups called

Medcare, Aster and Access. At some point of time in future we would like to expand it to

other countries including India.

Another very important point which differentiates us from other healthcare providers is

our major involvement in academics with an intake of nearly 1000 students every year

which helps us to have a pipeline of medical professionals. One of the most important

differential features is Aster Volunteers which is the CSR arm of Aster providing service to

large number of people every year in India. We believe that God has given us health and

wealth, part of which has to be given back free of cost to needy people.

Dr. Azad MoopenFounder Chairman and Managing Director, Aster DM Healthcare

10 FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE 11

not get into the syndrome of Chronic Heart

Failure that may leave them without many

options or commonly unaffordable treatment

options. Fame spread, the US FDA chose us

as the only hospital in Asia to be part of US

FDA global study for the Robotic arm to be

used in Angioplasty. Today the department

is recognized as a centre of excellence. The

hospital was the first in the country to utilize

the Bio absorbable stent. The department

handles complicated procedures as total

chronic occlusion (CTO). Our Cardiologist

is invited internationally to showcase these

acquired skills. This unit is now proctoring

offshore Cardiologists. Reversal of dominance

and a red letter day for the hospital, city and

India!! Today we are proud to state that we

are one of the 4 hospitals to be associated

with the American Heart Association to be

in a collaborative study for the treatment of

hypertension in Asians.

Hiranandani Orthopaedic Medical EducationThe hospital marched ahead in the field

of Orthopaedics. We were the pioneers in

computer navigation surgery in the city.

We devised protocols for patient safety that

have gained International recognition and is

published in leading Orthopaedic Journals.

This has resulted in a dramatic decrease in

post-operative complications. Also using

the computer navigation in most cases has

given fine results as cases performed in 2004

are being followed up in the hospital and

they are without any symptom. This is an

outstanding achievement as the incidence

of revision surgery increases after the first

decade. The department went into using

platelet rich plasma for chronic ligament

and joint paint with outstanding results.

Many a sportsperson has benefitted from

this therapy. Our Postgraduate teaching

program was developed under Hiranandani

Orthopaedic Medical Education (HOME).

Our work has gained us recognition as

being an Orthopaedic training centre by

SICOT (Societe Internationaale de Chirurgie

Orthopedique et de Traumatologie or the

International Society of Orthopaedic Surgery

and Traumatology). Many a young orthopod

has crossed these portals. The department

has evolved into a comprehensive centre that

Dr L H Hiranandani Hospital

Laboratory The National Accreditation For All Its ServicesFROM GETTING THE ISO CERTIFICATION IN 2006 THE

HOSPITAL TOOK THE GIANT STEP IN 2007 TO GET THE NABH

ACCREDITATION FROM THE QUALITY COUNCIL OF INDIA.

Inaugurated on the 22nd of February, 2004, the Dr L H Hiranandani Hospital is located

in the picturesque Hiranandani Gardens at Powai. Armed with the mission of ‘Being

the preferred choice for healing and good health’, the hospital set about its task of

engaging in rendering quality of care. And with very good reason, the hospital aspired to

mirror the long and illustrious career of a titan in the field of medicine in general and ENT

in particular – Padmabhushan Dr L H Hiranandani.

From getting the ISO certification in 2006 the hospital took the giant step in 2007 to get

the NABH accreditation from the Quality Council of India. This was a first not only in the

city of Mumbai but also in the Western region of India!! Thus not a single act of our hospital

coming into being remained mundane. The hospital marched on to get its Laboratory the

National accreditation for all its services (NABL) in 2008 and then marched on to even have

the Blood Bank get the NABH accreditation in 2011. The hospital has aspired for excellent

Nursing and this led us to also the Nurses to be recognized by the Quality Council with

Nursing Excellence in March 2016. We thus gave meaning to standardization in healthcare

as the hospital has refined process that are followed.

While quality has been the cornerstone of this dynamic outfit, professionally too we were

well recognized. Arguably ours was the first hospital to popularize and propagate Primary

Angioplasty in Myocardial Infarction (PAMI) and we not only saved lives but have also

ensured those afflicted do not have myocardial damage! This certainly means that they will

renders all forms of orthopaedic treatment, from joint replacement,

spine surgery, orthopaedic surgery, sports injury therapy and all this

encompassed with a sound physical rehabilitation centre that can

take care of each need right from removing pain to restoring strength.

Department of Obstetrics and GynecologyThe greatest joy that a family experiences is to welcome a new member

in its midst. Thus delivering the happiness quotient has been the ‘True

North’ for the Department of Obstetrics and Gynecology. Not only was

the department able to deliver this happiness, but soon turned into

a centre of excellence that could offer treatment for the woman from

‘womb to tomb’. Today the department has a diversified into many

specialized clinics. They are – Pre pregnancy counseling, Infertility (Male

and Female) or Human reproduction – The department also leads in

all techniques related to human reproduction with benchmarked

results. The equipment to deliver this sort of excellence is sourced from

leading vendors and with the expertise existing the results had to be

extraordinary. Surgical excellence has been the core competence in

the department. Today we perform the true ‘Stitch less’ vaginal surgery

for operations that are generally performed by the abdominal route.

Minimal access surgery is performed using all the available techniques

in the world. Pregnancy may be complicated and to address such

conditions we have the ‘High Risk Pregnancy’ Clinic. We also have

fetal medicine experts who have the skill to accurately diagnose fetal

abnormalities in early pregnancy that can be followed up and therapy

decided at birth or even early intervention when the baby is still in the

mother’s uterus. There are doctors who have a program for women’s

cancer risk prevention. Then again the menopausal clinic for the seniors

to live a life where they are active and can sustain on their own.

Process are validated for effectiveness and revalidated if any new

modality is introduced for better patient outcome. The hospital thus

has incorporated the clinical pathways for better patient outcome,

reduced hospital stay and also very minimal use of antibiotics. This

reduces the overall cost to the patient. Clinical pathways have also

ensured a degree of safety for patients. Early destarvation has resulted

in lesser use of antiemetic and also intravenous fluids.

The introduction of the system of integrated patient clinics has had a

great impact on patients. The coordinator in the department arranges

a meeting of the patient with a number of specialists together. Before

meeting the patient the doctors have already gone through the

detailed history and when they meet with the patient they are in a

position to tailor make a treatment plan for that one person. This make

the patient singularly well informed and at the same time they feel

involved with their own treatment as they now feel that they are also

an integral part of the team that is planning the therapy. This is a huge

confidence building measure for the patient. The hospital has over

50 service streams to render treatment. Those that have performed

remarkably well are Ophthalmology, Metabolic medicine including

Bariatric Surgery, Foot care and management, High Risk OPD for

Paediatric Evaluation and so on. The hospital has a social side too that

looks after the physically and mentally challenged.

The hospital was confident that it was on the track that Chairman

Hiranandani would have wanted. Thus to determine how good that

quality was, we competed at the Ramkrishna Bajaj National Quality

Award (RBNQ) for the first time in the year 2008 and were declared

winners pan India. The next year, 2009, we went on to compete at

the International Asia Pacific Quality Award and were also the winners

there. This possibly for the first time a hospital from India had bagged

this prestigious award. There were other accolades that followed. The

hospital again marched ahead to be the winner of the RBNQ for the

year 2015. In a span of 12 years we have imprinted the stamp of quality

in healthcare across the country.

Even before the inaugural stone was laid on the foundations of Dr

L H Hiranandani Hospital, in the first flush of the new millennium,

everyone associated with it could see that it was a more sublime affair

than mere brick and mortar. And with very good reason. When a yet-

to-be-born hospital, -however swanky, however massive, - aspires to

mirror the long and illustrious career of a titan in the field, the usual

concerns of hospital management and business blue-printing are the

first to go out of the window.

One chooses the nobler and brighter options over practical and gainful

ones, choices that are worthy of the name it is founded on. And when it

is a tribute to an iconic father by his almost equally accomplished sons,

it even transcends the question of honour. It becomes an act of love.

Today we are proud to state that we are

one of the 4 hospitals to be associated with

the American Heart Association to be in

a collaborative study for the treatment of

hypertension in Asians.

Super ICU:Such like work would not have been possible

with a strong Intensive Care Unit back up.

The hospital has the concept of a ‘Super ICU’.

The unit is capable of monitoring any and

every parameter required to treat a seriously

ill patient. The unit follows the best air-

conditioning standards. This is benchmarked

against stringent standards. There are special

units to treat the patient with very serious

infection called the negative pressure room

and the positive pressure room for the

patient who has little resistance to infection.

This unit is monitored by a large team of

full time Intensive care experts.

Dr L H Hiranandani Hospital

12 FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE 13

of the society. Sir Ganga Ram Hospital’s

doctors contribute to the hospital out of their

professional earnings, which is ploughed back

to maintain the growth and flagship of the

hospital. Due to this unique cooperative stake

holding of this hospital, the hospital is rightly

called “People’s Own Hospital”.

Service Excellence : Talent, Infrastructure The Board of Management is very particular

and fair in selecting intelligent, passionate

and compassionate doctors at the time of

induction and provides them an ambient

culture to further their skillsets and academic

growth. Every consultant is required to devote

adequate time for teaching and research. Sir

Ganga Ram Hospital is well sought by young

consultants and eminent doctors all across

India. We feel proud that so many of our doctors

who joined as young consultants have attained

national and international eminence in their

fields. Upcoming hospitals look up to Sir Ganga

Ram Hospital faculty for guidance and cutting-

edge approach. We are proud of our role as a

‘Nursery’ that stresses on training healthcare

professionals devoted to the society. To guard

against any malpractices, we have instituted a

strong medical ethical committee.

Patient ComfortHospital is continuously making efforts to

improve patient comfort and convenience.

Following steps have been taken:

OPD areas have been renovated with

adequate waiting space

Smart OPD concept to enable booking, Q

Management and hassle free consultations

Multi Level Car Parking commissioned in

2018 to facilitate parking of over 1000 cars

Future Plan: A new block with additional

beds and ultra modern Cancer Centre is

under construction and a separate OPD

block is also under construction

Sir Ganga Ram, an excellent civil engineer, great philanthropist and founder of Sir

Ganga Ram Trust Society established the first hospital in 1921 at Lahore, which is still

known as Sir Ganga Ram Hospital. In 1954, the Trust Society established a 50 - bed Sir

Ganga Ram Hospital at New Delhi. The Trust Society, in 1976 handed over the management

to the Board of Management, which comprised of eminent consultants from the hospital

itself. Through these turn of events, the Board of Management with its dynamic and visionary

leadership and guidance, and harmonious relationship with the Trust Society, directed the

hospital to reach its present eminence. At present, the 675-bedded tertiary care hospital

is equally known for quality and ethical healthcare and excellence in the field of medical

education and research. Sir Ganga Ram Hospital is now a role model for the National Board

of Examinations and provides postgraduate courses in 42 disciplines.

Making a difference to all sections of SocietyA dedicated and eminent faculty is our core strength. The Trust Society members render selfless

service and are committed to above-par and ethical healthcare, which is equipped with the

latest technology and provided to all sections of the society. The hospital runs free OPDs in the

morning in all specialities, which includes free consultations, highly subsidized investigations,

free drugs and free investigations to EWS category patients. In addition to that, the hospital

runs free emergency services round the clock and 20% of the indoor beds are reserved for free

medical care. Beds that are charged are divided into three categories as per different sections

GRIPMER : Innovation, Academics, ResearchWe strongly believe that medical education and research are essential

components in delivering quality and updated medical care. In order

to consolidate and further strengthen our academic and research

activities we established Ganga Ram Institute of Postgraduate Medical

Education & Research (GRIPMER) in the year 2012. GRIPMER has

signed agreements with various governmental & non-governmental

organizations of India as well neighbouring countries to promote

research and capacity building in training medical professionals. Sir

Ganga Ram Hospital is a pioneer in establishing an excellent Medical

Genetics department that offers a Ph.D. program.

We have got several research projects being funded by important

national organizations like ICMR, DST, Department of Biotechnology

etc. and significant international organizations like UNICEF, WHO and

others. The hospital is recognized as a Scientific and Industrial Research

Organisation (SIRO) by the Department of Scientific & Industrial

Research since 2000. Sir Ganga Ram Trust Society is committed to

reach rural population at their doorsteps through our charity outreach

program and telemedicine, which has best consultants on board.

Brand CommittmentSir Ganga Ram Hospital is firmly committed towards providing

excellent healthcare with passion and compassion while strictly

adhering to medical ethics. The hospital is devoted to impart

postgraduate medical education to doctors, producing dedicated

nurses and running structured para-medical courses to provide

competent medical professionals to the country. The hospital is

involved in meaningful clinical and molecular research and extends its

support to various government and non-government organizations

in promoting health and prevention of diseases. There are efforts to

promote alternative systems of medicine, too when clinically proven.

Message from the Chairman, Board of ManagementServing this great institution for the last 38 years and being one of

the pioneers in establishing comprehensive nephrology, dialysis and

kidney transplantation services in the non-government sector, I feel

privileged to give back to the institution by serving Chairman of Board

of Management since 2011.

The hospital is

recognized as a Scientific

and Industrial Research

Organisation (SIRO)

by the Department of

Scientific & Industrial

Research since 2000.

CORE VALUES Sir Ganga Ram Hospital is a patient-friendly

hospital with a “Patient First Policy”. It is

committed to holistic healthcare, cutting-

edge research and a training ground

for competent healthcare professionals.

State-of the-art technology has been the

hospital’s key strength. We have been

the first in acquiring latest technologies

over last four decades. It is a doctor

and an employee-friendly hospital. The

management is transparent and open-

minded. Both service providers and service

takers have a sense of belonging

and are partners in the

growth of the hospital.

I believe that all tertiary care hospitals should endeavor to provide

quality and affordable healthcare at the doorsteps of rural India. The

Government should give land on lease to genuine NGOs and further

infrastructural support should come by India Inc as part of their CSR

activities. Tertiary care hospitals should further provide expertise of

their talented doctors and help in capacity building of these centres

to eventually make them self-sustainable.

The Medical Council of India should regulate the quality of medical

education and pay the pedagogy adequately. Besides, controlling the

price of life-saving drugs and promotion of generic drugs, the Drug

Controller should ensure quality.

Sir Ganga Ram Hospital Marg, Rajinder Nagar, New Delhi - 110060, 24 Hour Helpline : 25750000, 42254000, Fax: +91-11-25861002, E-mail: gangaram@sgrh.com Visit us at www.sgrh.com

People’s Own HospitalSir Ganga Ram Hospital is now a role model for the National Board of Examinations and provides postgraduate courses in 42 disciplines.

Dr. D.S. RANA, MBBS, MD, MNAMS, FISN, DSc, FGSIAwarded Padma Shri by the Hon'ble President of IndiaDr. B.C. Roy National Awardee

Chairman, Board of ManagementChairman, Department of NephrologyTrustee, Sir Ganga Ram Trust Society

14 FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE 15

Ballal, the Chairman of Manipal Health

Enterprises, adds, “At MEMG, the technology

initiatives provide the freedom to deliver new

pedagogic methods and systems of learning.”

Each of the skills imparted are extremely

relevant and welcomed in the corporate

sector, the advantage of wearing two hats -

the teacher and the business leader.

That said, Pai’s healthcare business is

also providing to be a sweet spot with

investors. Recently, Singapore’s state-owned

investment company Temasek Holdings

bought out private equity investor True

North’s entire 18% stake in the hospital chain

for `1,100 crore, valuing the Company at an

estimated $1 billion. Already an established

hospital network in South India, it was

inevitable that Manipal Health would eye

a pan-India expansion at some point. Dr

Ranjan Pai wants to entrench the Manipal

brand in healthcare, not just in India but also

in other countries. The Company already has

a network of 10 hospitals across India, with

4 hospitals managed and, additionally, has

one in Malaysia, and a clinic in Nigeria—

with close to 6,500 beds, of which the city

of Bengaluru alone has 1,100 beds. Manipal

Health has now forayed into the north and

has a 300-bed multi-specialty hospital in

Jaipur, Rajasthan, and one in Dwarka, New

Delhi, with 450 beds.

Manipal Health has also built its business

around the tertiary-care model and is not

dependent on one particular specialization.

“We have centers of excellence and some

of the best doctors in the country - who are

leaders in their fields, extremely competent

support staff that delivers on global

standards, and skillful med-support.” added

Dr. Ballal. The culture of social sustainability is

driving excellence in the healthcare brands.

The brand’s vision to provide affordable

healthcare comes from a deeply insightful

space. With a view to contribute a solution

to the inaccessibility of affordable healthcare

across the country, Manipal Health has

partnered with the Government of India’s

initiative - Ayushman Bharat, a health

insurance cover of ` 5 lakhs per family, for 50

crore beneficiaries from below poverty levels,

constituting around 40% of the population,

for secondary and tertiary care hospitalization.

also incubates start-ups affiliated to these

sectors.

However, the basic premise of all the

companies and institutions under the MEMG

umbrella stays the same today - a charter that

requires them to offer socially relevant and

affordable services. But this was the basic

premise of Dr. TMA Pai’s vision, all along - his

firm belief that if every person of our country

has access to good education and healthcare,

the person will have a good livelihood and

be a productive citizen. Interestingly, in the

1990s United Nations, defined the eco-socio

development status of a country through

a “human development index”, where two

of the three components of the index were

the education level and health status of its

people – a fact Dr. Pai recognized over half a

century ago.

The focus of MEMG is to contribute towards

creating human skill pools in the country

to support economic development by

setting up educational institutions. This

creation of skill pools has extended to other

countries too, especially in Malaysia and

Nepal. Over the years, Manipal graduates

in clinical, engineering, management and

other academic disciplines have contributed

significantly to the economic and industry

development in regions across India and in

countries overseas.

MEMG, today, is one of the foremost umbrella

institutions in India. It combines world

class skills development with sustainable

enterprise - and under the guidance of Dr.

Ranjan Pai, leverages technology to move

ahead with futuristic visions. Dr. H Sudarshan

The Manipal Experience

He might be a doctor by training but he’s better known as an astute investor and a

successful entrepreneur. Defying conventional wisdom that says doctors can’t be

good businessmen, some people have the ability to work for the society and also raise

successful, sprawling business enterprises. One of whom is the Bengaluru-based billionaire

entrepreneur Dr. Ranjan Pai who heads an Education and Healthcare empire in India.

The Pai family has been operating in the field of education for three generations as the Manipal

Education and Medical Group (MEMG). Padmashri Dr. Tonse Madhava Ananth Pai, Ranjan’s

grandfather, set up India’s first private, self-financed medical college in 1953, in Manipal, in

the State of Karnataka. Over the years more colleges were set up in various disciplines and

in 1993 this institution was given a university status and became the Manipal Academy of

Higher Education (MAHE), which, recently, has been recognized by the Government of India as

an “Institution of Eminence. The educational institutions grew in leaps and bounds under the

leadership of Ranjan’s father, Padma Bhushan Dr Ramdas M Pai, who expanded the footprint

beyond Karnataka to set up universities and educational institutions in Sikkim and overseas in

Malaysia, Nepal, Dubai and Antigua.

Continuing with the strong legacy, Ranjan professionalized the operations and established

Manipal Education and Medical Group as a corporate enterprise. Moving on from just education,

MEMG’s offerings, today, are broadly spread across four key verticals of Education, Healthcare,

Research and Foundation. A recent investment entry is in the health insurance sector. MEMG

At MEMG, the

technology initiatives

provide the freedom to

deliver new pedagogic

methods and systems

of learning.

Dr. Ranjan PaiGroup Chairman, Manipal Education and Medical

Delivering Excellence in Healthcare and Education:

Says Dilip Jose, MD & CEO of Manipal Health Enterprises, “With plans to provide the best in class

primary, secondary and tertiary healthcare, we think that Ayushman Bharat is very relevant

initiative for our country. With 15 hospitals, including our teaching hospitals, and over 6000

beds, we can extend our support to geographies that are underserved in healthcare. While the

basic building blocks for affordable healthcare are in place, what is needed is a progressive and

proactive approach, backed by innovation, to healthcare delivery.”

Over the last few years, Dr Ranjan Pai has gained the reputation of being a patient investor who

has built a very focused yet diverse portfolio. His willingness to channel funds into startups that

focus on high-risk sectors such as life sciences and biotechnology where investor interest is

usually low—has won him the admiration of peers and entrepreneurs.

Leveraging technologies like artificial intelligence (AI), blockchain, and data analytics to provide

this support, is another of Dr. Pai’s vision for MEMG. Generating and using data to improve health

outcomes, maintain electronic health records and cloud storage and even consumer-facing

mobile apps, empower patients as well as healthcare providers to deliver much better service.

As Dr. Ballal, says, “We at Manipal Health are committed to providing a patient centric, clinically

excellent and an ethical-technology driven health care. We are also looking at a viable PPP

model to drive the exciting, yet challenging, universal health care mission of the Government’s

Ayushman Bharat, the largest of such initiatives in the world.”

Padmashri Dr. Tonse Madhava Ananth Pai, Ranjan’s grandfather, set up India’s rst private, self- nanced medical college in 19 , in Manipal, in the State of arnata a.

Dr. H Sudarshan BallalChairman, Manipal Health Enterprises

Dilip JoseMD & CEO, Manipal Health Enterprises

“We at Manipal Health are

committed to providing a

patient centric, clinically

excellent and an ethical-

technology driven health

care. We are also looking at

a viable PPP model to drive

the exciting, yet challenging,

universal health care mission of

the Government’s Ayushman

Bharat, the largest of such

initiatives in the world.”

“With plans to provide

the best in class primary,

secondary and tertiary

healthcare, we think that

Ayushman Bharat is very

relevant initiative for our

country. With 15 hospitals,

including our teaching

hospitals, and over 6000 beds,

we can extend our support

to geographies that are

underserved in healthcare".

16 FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE 17

around mid-forties. Lack of awareness about disease symptoms,

early diagnosis contribute to late diagnosis, delayed treatment and

high mortality. Unnecessary Mastectomy (i.e, total breast removal) is

common practice which scares women from receiving appropriate

institutional treatment. Therefore, considering the growing BC burden

in India, OBHC has developed multi-pronged, high-impact, innovative

initiatives in the fight against BC.

International Standards in BC Clinical Management1) Advanced Breast Cancer Diagnostics

OBHC is equipped with sophisticated imaging modalities such as

Contrast Enhanced Digital Mammography with 3D Tomosynthesis

(first in India) and Automated Breast Volume Scanner. Precision biopsy

procedures with Vacuum-assisted Biopsy and Robotic arm-guided

Stereotactic biopsy are available at affordable rates.

2) Pioneering Breast Oncoplastic Surgery in India

BOS is a new paradigm that combines principles of BC surgery and

cosmetic surgery in the same sitting.Loss of breast via mutilating

surgeries can lead to psychological trauma and depression, thereby,

decreasing survival rates. BOS allows for tumor removal, breast

shape and size restoration and good cosmesis in a single surgery.

BOSpositively impactspatient psyche, self-esteem and body image

resulting is better quality of life.

Under the leadership of Dr. Koppiker, an international renowned

surgeon and it’s Medical Director, OBHC has pioneered BOS in India. At

OBHC, about 75% patients undergo breast saving BOS procedures. In

20% of cases that absolutely require mastectomy,breast reconstruction

is performed in the same sitting in majority of cases. The rates of

total mastectomy are as low as 4%, perhaps, one of the lowest in the

world.In the past 5 years, OBHC team has performed over 1500 BOS

procedures with various innovative techniques.

TrainingWith an objective of reducing mastectomy rates in India by creating

a well-trained BOS work-force, OBHC and senior surgeons from the

University of East Anglia (UEA), UK have conducted hands-on training

workshops. Dr. Koppiker has been conferred with a faculty position

in the University of East Anglia, UK and the American School of

Oncoplastic Surgery.

In 2017, OBHC and UEA have jointly started an academic degree

program (M.Ch. in Breast Oncoplasty) which is the only course in

Asia offering cutting-edge BOS training (www.breastoncoplasty.

org). Over 50 surgeons from India and South East Asia (Sri Lanka,

India's State-Of-The-Art Breast Cancer Centre

Orchids Breast Health Center (OBHC), an initiative of the Prashanti

Cancer Care Mission (PCCM) Pune , is a one-of-its-kind ‘Centre

of Affordable Excellence in Breast Care in India’. OBHC has

pioneered several innovative techniques in breast diagnostics and

surgery – ONCOPLASTIC BREAST SURGERY. It is a unique research-

driven enterprisecomprising of a team of onco-clinicians, radiologists,

geneticists, clinical scientists, physicians, psycho-oncology counselors

and dieticians at its core. OBHC has blended state-of-the-art clinical

management strategies with community outreach, training and research.

OBHC Initiatives for Fight against Breast Cancer (BC) in IndiaAccording to WHO, breast cancer is now the most common cancer

in India affecting all socio-economic strata of the society (1, 62,468

new BC cases diagnosed annually) with highest global mortality rate.

Majority of BCs in India are detected in young, premenopausal women

Indonesia, Maldives, Afghanistan, Bangladesh) have enrolled full-time

in the program while over 500 surgeons have been trained in various

workshops conducted all over India.

Translational Breast Cancer ResearchIndian BC cancer profile is different than other countries with reference

to its epidemiology, clinico-pathology as well as clinical management.

Unlike the west, majority Indian BC cases are diagnosed in advanced

stage and predominantly in young, premenopausal women. Triple

negative breast cancer (TNBC) is an aggressive and difficult-to-treat

disease highly prevalent in Indian women. Hence, it is incorrect to

directly extrapolate research findings from western population in

treating Indian BC patients.

All leading international cancer hospitals (i.e., M.D. Anderson

Cancer Centre, Houston, USA, Institute of Cancer Research, London)

have established highly successful cancer research programs. On

similar themes, PCCM has joined hands with Indian Institute of

Science Education and Research (IISER), a premier national research

institute in Pune in 2017 to establish a Centre of Translational Cancer

Research (CTCR), supported by seed fund from Bajaj Auto Ltd. CTCR

has undertaken major BC themed-research relevant to Indian context

in the themes of public health, epidemiology, genetics, OBS, chemo-

radiation and psycho-oncology.

CTCR research agenda includes understanding the molecular basis

of high prevalence of TNBCs in India population.Fruitful collaborations

with world-renowned breast cancer clinicians and researchers from

USA and UK have been established. Unique TNBC genetic patterns and

molecular biomarkers have been identified that will be helpful to the

Indian onco-clinicians in better prevention, diagnosis and treatment.

CTCR has also undertaken major initiatives in capacity building of

cancer researchers by conducting novel training programs in research

methodology, molecular oncology, bioinformatics, preclinical and

clinical research. In September 2019, CTCR will be hosting the first-

ever conference in Indian based on ‘The Cancer Genome Atlas ( TCGA)

which is world’s largest open-source database for cancer research

funded by National Cancer Institute , USA.

Community Outreach1. Sensitization

Based on WHO guidelines, OBHC conducts BC awareness campaigns

in Pune that sensitizes thousands of women in Pune annually.

ImportantBC-related information is provided in all languages to dispel

myths about the signs, symptoms, diagnosis and treatment aspects

with an emphasis on quality of life. In addition, regular symposia are

organized for the community to discuss breast cancer related issues

with experts. OBHC also organizes one of Pune’s largest breast cancer

awareness marathon (‘Our Marathon’) with over 15,000 participants.

2. Screening

OBHC has created aClinical Breast Examination (CBE)-based screening

program in which women are examined by breast palpation

performed by well-trained para-medicals and medical social workers.

A mobile mammography project was created to screen women

(above 40 years) for breast abnormalities in which trained radiologists

examined the mammograms.In2016-17 over 50,000 women were

sensitized via awareness talks and 6500 women were screening

using CBE and mammography. The diagnosed cases identified via

this screening program were treated free of cost at OBHC.

3. Chemotherapy Corpus

With the help of generous donors, OBHC has also created a

chemotherapy corpus to provide free and concessional life-saving anti-

cancer drugs, including Herceptineto underprivileged patients (1238

concessional and 539 freeships amounting to over 2 Cr in FY 2018-19)

4. Patient Support

Rehabilitation is the most important arm of breast cancer requiring

significant support from family and friends, OBHC has created a

PINK -RIBBON support group which provides support to patients

and caregivers via organizing transport, babysitting, nutritional

programs,psychological counseling, picnics and get togethers.

These initiativesare spearheaded by Ms.LalehBusheri,(CEO, PCCM)

and members of the support group. The aforementioned high-

impact projects of PCCM and CTCR will receive a significant boost

with generous support from socially-conscious organizations and

individuals. Therefore, it is our earnest appeal to corporate houses,

high-net worth individuals, philanthropists and NGOs to join hands

with PCCM in the fight against breast cancer in India by supporting

the ongoing and future activities; with the credo “Losing is Not an

Option - Be it Hope, Breast or Life”.

OBHC ACHIEVEMENTS

Global recognition as pioneers in Breast Oncoplastic Surgery (BOS) in India

Largest number of BOS cases (over 1500 oncoplastic and reconstructive procedures)

Pan-Asia training BOS training program State-of-the art advanced breast cancer radio-

diagnostics and precision biopsies Translational cancer research in collaboration with

reputed national and international partners Innovative social-impact, community programs in

breast cancer awareness and prevention

Dr. C B KoppikerTraining surgeons at LA

A one-of-its-kind centre that has pioneered several innovative techniques in breast diagnostics and surgery.

Training Workshop with UK Faculty

Laleh BusheriCEO, Prashanti Cancer Care Mission (PCCM)

18 FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE 1918 FORBES INDIA MARQUEE . LEADERS

autism has been published by NeuroGen Brain & Spine Institute, in the

prestigious journal Stem Cell International.

In adults, Stem cell therapy performed at NeuroGen brings

about inspiring improvements in the paralytic symptoms of patients

with spinal cord injury, brain stroke and head injury. In deteriorating

conditions, like motor neuron disease, muscular dystrophy and other

neurodegenerative disorders, it offers lifesaving, stabilizing treatments

and improves the quality of life of patients, infusing vitality in their day-

to-day lives. Since its inception in 2008, NeuroGen has successfully

treated over 8000 patients from over 65 countries. We have been

accredited by ISO 9001-2015 and have a GLP (Good Laboratory Practice)

and GMP (Good Manufacturing Practice) certified stem cell laboratory.

Mission & Vision To make a difference to the lives of patients suffering from

incurable/intractable diseases and injury of the nervous system,

by providing them with the most effective and safest available

treatments & technologies from the field of neurosciences and

regenerative medicine

To offer return of function, relief from symptoms and recovery from

illness in a professional, holistic and caring manner in a world-class

institution

To conduct basic & clinical research and to constantly work on

innovation & development so that the best therapeutic strategies

can be evolved

Our People A medical team (Neurosurgeon, Neurophysician, Pediatrician,

General Physician and Anesthetist)

A basic science team (Neuropathologist and Regenerative

Medicine Scientist)

A rehabilitation team (Physiotherapist, Occupational therapist, Clinical

Psychologist, ABA Therapist, Pediatric Physio Therapist, Speech

Therapist, Aquatic therapist, Special Educator and Nutritionist)

OUR RESEARCHAt NeuroGen, there is a strong emphasis on honest, diligent academic

work and rigorous clinical research, along with patient treatment. A

detailed and unbiased analysis of the clinical data is carried out and

published in various scientific journals on a regular basis, so that there

is transparency about our work. Currently, 86 scientific papers have

been published by our team in various international and national peer-

reviewed medical journals. We also have 7 chapters in International

textbooks, in addition to 16 published books.

AWARDS RECEIVED:NeuroGen has achieved awards in various National and

International forums, as below:

National Awards

“The Best Stem Cell Therapy centre in India” by National Healthcare

Excellence award in 2016 at New Delhi, India.

“The Best Stem Cell Therapy center in Maharashtra” by Navbharat

Healthcare Excellence award, June 2017 at Mumbai, India.

“Best Super Specialty Hospital” of the year January 2017, at New

Delhi, India.

Dr. Alok Sharma: Brings Extensive Surgical Expertise In The Areas Of Neurosurgery

NeuroGen Brain & Spine Institute, Navi Mumbai, India is

an international center of excellence for neurological

disorders. Founded on 17th December 2008 by a renowned

Neurosurgeon, Neuroscientist and Professor Dr. Alok Sharma,

it has been set up specifically to treat incurable neurological

conditions, through a combination of stem cell transplantation and

comprehensive neurorehabilitation.

Dr. Sharma brings with him extensive surgical expertise & experience

in the areas of Neurosurgery, Neuroscience and Regenerative Medicine.

A trailblazer in the field of Stem cell therapy for neurological disorders,

he has over 25 years of experience in the field of Neurosurgery and has

several awards and recognitions to his name. He has authored 16 books

and has over 150 scientific papers published in various medical journals.

NeuroGen has played a pivotal role in developing revolutionary

treatment for children with Autism, Cerebral Palsy, Intellectual Disability

and other neurological disorders. The knock-on consequences of

our therapy result in improvements of their cognitive abilities and

helps them to seamlessly integrate back into mainstream society.

The world’s first scientific publication on the role of cell therapy in

“Quality Heath Services in Neuro Sciences” by International

Excellence Awards, March 2017, at Goa, India.

“International Excellence Award for Service to Disabilities” by

Hon’ble Minister of Government of India Minister of Social Justice

and Empowerment, Delhi (August 2017)

“Emerging Stem Cell & Neurology Centre in the year (India)” by

Brands Academy Award in December 2016 at New Delhi, India.

“Excellence in Stem Cell Therapy in Maharashtra” by India Today

Excellence Health Care Award at Mumbai (June 2018)

“Best Stem Cell Research Hospital in India” at the hands of

Dr. Anupriya Patel, Hon'ble Minister of State in the Ministry of

Healthcare & Family Welfare, Government of India (Nov. 2018)

International Awards

“The Rose of Paracelsus Award, by EMA (Oxford UK)” at Cannes,

France, October 2016.

“European Awards for Best Practices 2018” by European Society

of Quality Research at Brussels, Belgium, May 2018.

“Inspirational Company” by World Confederation of Business at

St. Thomas, Virgin Islands, USA, July 2017.

“Best Hospital” Europe business assembly (EBA) at Dubai,

January 2017.

What is Stem Cell therapy and how does it help patients with incurable neurological disorders?Stem cells are specialized cells that can potentially convert into any type

of tissue under specific physiological conditions, and have the ability

to repair damaged parts of our body. Stem cell therapy is a simple and

effective treatment and is 100% safe when autologous adult stem cells

are used. Statistics have shown that, after Stem cell therapy, overall

90% of patients with Autism have shown improvements in social

relationships, emotional responses, speech, communication, behavior

and hyperactivity. 77% of Stroke patients showed improved upper and

lower limb activity, 96% of patients with Spinal Cord Injury showed

better muscle tone, trunk activity, balance and other activities of daily

living. In Cerebral Palsy, 91% of treated patients showed improvement

in oromotor/speech functions, balance, and upper/lower limb activity.

In Muscular Dystrophy, which is a progressive disease of the muscles,

about 86% of the patients attain stabilization of their condition, along

with improved functionality.

Dr.Alok Sharma (M.S, M.Ch.) Director – NeuroGen Brain & Spine Institute, Navi Mumbai

Over 2 years of experience in the eld of Neurosurgery and has several awards and recognitions to his name.

FACILITIES PROVIDED:

Eleven floors, 75 bedded hospital with all the Medical and

Surgical facilities with state-of-the-art Stem Cell Laboratory

All the Neurorehabilitation Dedicated departments for various

therapies such as Physiotherapy, Occupational Therapy, Neuro-

psychological intervention, Speech therapy, Neurodevelopmental

therapy and Diet Counselling

Dedicated Autism Child Development Centre that involves

complete assessment and evaluation of the child, Neuroimaging

tests and all kind of therapies like Applied Behavior Analysis

(ABA), Occupational Therapy, Psychological Intervention, Special

Education, Speech Therapy, Dance Therapy, Art Therapy, Play

Therapy, Music Therapy, Physiotherapy, Group Therapy, Animal

Therapy, Family Counseling, Pharmacotherapy (Medications).

One-of-a-kind facilities in the country, including a Spinal Cord

Injury Walking Track, which empowers wheelchair bound spinal

cord injury patients to come back on their feet, as well as Aquatic

Therapy to enable patients to freely perform movements that are

difficult to perform on land.

CORPORATE SOCIAL RESPONSIBILITY:

As an institute, we understand that coping with a neurological

disability is as traumatic to the patient’s family as it is to the patient.

Hence, we aim to extend our support in every possible way, not just

before or during the treatment, but also beyond. As its corporate

social responsibility, NeuroGen Brain and Spine Institute has

been helping out patients financially from lower socio-economic

background as well.

We at NeuroGen always strive to make our patients independent and

spread smiles, by bringing a paradigm shift in the treatment methods

employed for patients with intractable neurological disorders. Our

future is full of hope, with plans to expand our work by establishing

multiple centers of excellence worldwide. We wholeheartedly believe

in formulating superlative therapeutic strategies for our patients, that

extend their functional abilities to the maximum possible extent and

restore their faith in the beauty of life.

NeuroGen Brain & Spine Institute

Sector 40, Plot No 19, Near Seawoods Grand Central Station,

Off Palm Beach Road, Nerul (W), Navi Mumbai -400706.

Mob: 9920200400, Tel:022-41136565,

Email: contact@neurogenbsi.com, Web: www.neurogenbsi.com

20 FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE 21

Jupiter’s approach of ‘Patient First’ has inspired them to bring the

best aspects of modern medicine along with state-of-the-art

infrastructure under a single multi-functional premise, right from

day one. With the belief that patient-centric care is much more

than just clinical skills and medical care, the hospital focuses

on providing cutting-edge technologies and state-of-the-art

infrastructure to provide comprehensive and advanced care to

patients as well as their families.

With a vision to provide the country with a convenient one stop

access to multi-therapy services that cater to the rehabilitation

needs of the patient, a comprehensive neuro rehab department

has been set up in Jupiter Hospital Thane, Mumbai. The Jupiter

Neuro Rehab Centre provides interdisciplinary rehabilitation and

is one of the finest in world, with the latest robotic and assisted

devices for inpatients as well as its outpatient rehab patients. A key

feature of the centre is the ability to manage complex disabling

conditions with robotic, computer assisted rehabilitation & aquatic

rehabilitation. Neuro rehab provides specialized management for

people who have physical and/or cognitive impairments as a result

of brain or spinal cord injury, stroke, cerebral palsy, Parkinson’s

disease or other progressive and non-progressive neurological

condition. It includes musculoskeletal conditions as well.

The centre also offers a unique Aquatic Rehabilitation Program

which comprises of Asia first aquatic gym which is a temperature

controlled pool, with 5 gym equipment with graded resistance

inside the water. This aquatic gym utilizes the unique properties of

warm water to promote faster recovery for patients with Stroke, Brain

injuries, Spinal cord injuries, physical weakness/deconditioning,

fibromyalgia, low back and neck pain, sports related injuries,

arthritis, orthopedic injuries/surgeries. Supported by the buoyancy

of warm water, patients are able to perform therapies that increase

Jupiter Hospital:Paralysis Rehab The most advanced neuro-rehabilitation center in Jupiter Hospital comprises of unconventional robotic and computer-assisted therapy and also houses Asia’s rst aquatic rehabilitation pool.

Established in 2007, Jupiter Hospital has been operating as one

of the finest built multispecialty hospitals with well-planned

infrastructure and facilities in the city of Thane in Maharashtra,

India. The 375+ bedded, NABH and NABL accredited tertiary care

hospital, has been successful in catering to the rising healthcare needs

of the growing population of Thane and beyond. Recently recognized

as the Hospital of the Year in Healthcare Asia Awards 2019, the hospital

caters to all branches of medicine right from maternity and newborn

care up to geriatrics and palliative care. Jupiter’s second hospital in

Pune was established in 2016 and is the region’s finest integrated

healthcare facilities with world-class infrastructure, latest technologies

and skilled doctors.

strength and muscle tone, range of motion

and mobility; all while decreasing pain

and improving overall well-being. Specific

aquatic exercises for strengthening, balance,

coordination, spasticity & deep stabilization

are also an essential part of aquatic rehab.

“Rehab is an important part of a patient’s

journey to complete recovery”, says

Dr. Amit Ramesh Dhumale, Director of

Neuro-rehabilitation at Jupiter hospital.

"A well-planned rehabilitation program

plays a crucial role in helping a patient learn

to work around the challenges and live an

independent life. With the state-of-the-art

rehab centre, we have taken a positive step

A well-planned

rehabilitation program

plays a crucial role in

helping a patient learn

to work around the

challenges and live an

independent life. With

the state-of-the-art rehab

centre, we have taken

a positive step towards

providing something very

unique to India.

towards providing something very unique to India. While our department has a 200 sq ft

exclusive gym area, what is more important is that we have the comprehensive skill sets and

the best of equipment that provides conventional therapy as well as a whole set of computer-

aided and robotic rehabilitation devices. Each of these device has been selected after a

thorough study of what would be beneficial to a patient in the Indian scenario. And it is a

matter of pride for Jupiter, that the we are able to offer technology and care that is superior

than some of the most advanced cities in USA”.

Highlighting the need for such inter-disciplinary neuro rehabilitation in the country, he says,

“A coordinated, structured and integrated rehabilitation program helps restore a patient’s

physical & cognitive function in the best way, thereby enabling him to lead a normal life. It

is the need of the hour to have such setups in India, and we believe that more such setups

should be established all across the country. In the US for instance, there are around more 500

well-equipped state-of-the-art rehab centres, while in India we have only 4-5 rehab centres

that are well-equipped and in the position to treat patients with such problems”.

In addition to out-patient & day care programs, the centre is supported by five dedicated

inpatient beds (special rooms) with a first-of-its-kind system of lift hoists for each bed that will

get the patient from the bed to the centre. The centre – with its state-of-the art facilities and a

well-trained team - aims to provide convenient, individualized, safe, timely, compassionate &

highest quality of rehabilitation care to patients.

22 FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE 23

lab or a nurse handling hazardous drugs or a physician prescribing

medication—from anesthesia delivery to syringes and needles.

Trusted partnerships have provided impetus to this journey of

redefining medication management technologies to support health

systems in making their processes safer, smarter, and simpler.

In 2019, BD Global Health signed a MoU with USAID/India to

collaborate on a strategic partnership to advance GoI’s aim to

improve health outcomes by strengthening health systems in the

key priority areas of Tuberculosis, Antimicrobial Resistance, HIV/

AIDS, Family Planning and Maternal & Child Health.

Labs for Life (L4L) is a global, multi-country partnership between

CDC and BD; helmed by NACO in India and implemented by

CMAI. It aims to strengthen laboratory systems by enhancing

testing capacity, improving quality of services, strengthening

sample referral mechanisms, and ensuring sustainability of

interventions. The project is now in its third phase with a renewed

focus on consultation and agreement with all the stakeholders on

improving HIV and TB laboratory services.

In April 2019, we launched a new patient safety program for

hospitals, called Preventing Risks of Infections and Medication

Errors in IV Therapy (PRIME) with Joint Commission International

(JCI) to address the two critical challenges in a hospital setting

- infection prevention and medication safety. PRIME is a Gold

Standard benchmarked safety program that will help enhance

patient and clinical outcomes by eliminating complications and

improving safety for patients and providers leading to accessing

better care.

countries including Europe, Middle East, Africa, South East

Asia, Korea, Japan, Australia and New Zealand. As science and

technology transform our markets, the creativity, innovation

and commitment of 300 people employed at Bawal remain

critical to our success in India.

Not only do our associates wake up to embrace the

opportunity to bring life-changing innovations to market, but

this also creates a new day for healthcare providers, researchers

and patients. As India expands its healthcare horizons, we

continue to bring our experience in infectious disease

diagnosis and infection control, immune system monitoring,

improving medication and supply management, bringing cost

efficiencies in procedural areas, helping clinicians reduce the

risk of infections and advancing patient care.

Advancing healthcare with skill building and trusted partnerships Our unwavering commitment to healthcare is not only driven

by company results but more so from our passion towards

helping those who deliver healthcare. From hospitals to

pharmacies, the nursing wards to operating theatres and

the 'patient's bedside’, BD's products and services penetrate

through many layers of healthcare. By improving medical

discovery, diagnostics, and the delivery of care, we at BD seek

to empower the service providers; be it researcher in the

Unwavering Commitment to Healthcare

Every day is a new opportunity to make a difference in an evolving

world and advance the world of health. Over the last 120-plus years,

BD has been a critical supplier to the healthcare industry with a legacy

of innovation. From the first safety-engineered syringe to the first evacuated

blood collection tubes, the first commercial fluorescence-activated cell

sorting system, the first automated medication dispensing cabinet and the

first smart infusion pump, BD has been a leader in helping clinicians be more

efficient and cost effective while helping to improve patient and healthcare

worker safety.

With an overarching vision to improve patient outcomes in India, our journey

began in 1995 with the setting up of the world-class manufacturing plant

in Bawal, Haryana. Spread across 12.5 acres of land, the plant has a capacity

to churn out over a billion medical devices and also exports to over 50

This is evident in our approach to emerging

worldwide health concerns, such as

antimicrobial resistance (AMR), which

could possibly cause up to 10 million

deaths annually by 2050, surpassing deaths

currently caused by cancer.

Advancing the world of health: Becton Dickinson India Pvt Ltd

BD has been a leader in helping clinicians be more ef cient and cost effective while helping to improve patient and healthcare worker safety.

Technological BreakthroughsDeveloping the next generation of solutions for clinicians and

researchers is just the beginning of our industry leadership. As we

grow into one of the top five largest medical technology companies in

the world, we are also leading in areas that are critical to the future of

our industry and to society at-large. This is evident in our approach to

emerging worldwide health concerns, such as antimicrobial resistance

(AMR), which could possibly cause up to 10 million deaths annually by

2050, surpassing deaths currently caused by cancer.

We no longer focus on just new products, but instead we determine

how we can bring a suite of products and services to solve customer

challenges. We are redefining medication management technologies

to support hospitals and health systems to make their process safer,

smarter and simpler. BD continues to be on the front lines of helping

medical researchers develop a new generation of diagnostics and

therapies through our expertise in bioscience and genomics.

Many life-changing inventions are the result of scientific breakthroughs.

One such is BD Vacutainer® Tube. For Joseph Kleiner, a personal event

served as motivation to design a product that would revolutionize

blood collection. His idea sparked into the “Evacutainer” blood collection

system that was patented in 1949 and later become known as the BD

Vacutainer® Tube. 2019 marks the 70th anniversary of the tube’s patent.

From supporting medical research, enhancing diagnosis of infectious

diseases and cancer, promoting infection prevention, equipping

surgical and interventional procedures to supporting the management

of life-threatening diseases, one thing remains constant— BD’s

unwavering commitment to doing what is right.

As we walk the long, arduous journey of quality healthcare, we are

inspired by our role in serving the caregivers, researchers and other

healthcare professionals who serve patients. At BD, we will continue

to drive forward and innovate because we know there is a patient at

the end of everything we do.

24 FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE 25

When we did a detailed business field analysis

of the healthcare scenario, with particular

focus on the needs in India, we realized

that the healthcare needs of our country

are diverse. Though healthcare in India is a

necessity, it still comes packaged as a luxury

to the vast majority. We are burdened by

a combination of infectious diseases and

lifestyle diseases in our country. Innovative

solutions, unconventional business models

and unorthodox care delivery systems

would be the key drivers of healthcare.

Indian healthcare is on the cusp of a digital

transformation. India’s digital connectivity is

poised to grow at an accelerated rate from 30

per cent in 2017 to 80 per cent in 2034, and is

driving the following trends:

a. Flipped care: Similar to most sectors

around the world, focus has shifted from

the provider to the patient. “Flipped

health care” puts control in the hands

of patients, with the goal of improving

health and care delivery while also

reducing the cost.

b. Digital Health: This is a real game

changer. It is just not the App on the

Bosch technology offerings could be put to use, to improve the quality of people’s lives.

Bosch: Innovative products and solutions in the healthcare space

Technology and in particular, the Internet of Things (IoT) is fundamentally changing all

facets of life, from how we live, work and get around - homes are becoming smarter,

factories more productive, and mobility is taking on a fundamentally new form. True to

its tagline, “Invented for life”, Bosch is constantly developing innovative Connected Products, with

an intention to make all aspects of life easier. One such area, where Bosch is looking at to make a

fundamental impact on human life is healthcare.

Robert Bosch Engineering and Business Solutions (RBEI), headquartered in India, was

incorporated as a software development center of Bosch in the year 1997. With currently over

20,000 associates, RBEI is a strategic partner powering Bosch Business divisions worldwide.

RBEI healthcare believes that the future is in ‘Connected world’ inhabited by ‘Connected Life’

and aims to be a partner of choice to deliver IoT enabled innovative healthcare solutions for a

large scale, mass impact. “With a strong linking of our technology expertise in sensors, software

and services, RBEI healthcare is a preferred partner in the international marketplace and is

transforming the core nuggets of care delivery” says Guruprasad, VP Healthcare at RBEI.

mobile phone, but putting to use the computing power of

today’s smart phones for delivering Point of Care diagnosis and

last mile connectivity.

c. Front line innovations: Low-cost portable innovations to cater to

the needs of our vast rural population will help increase access by

providing Point of Care diagnostics, tele and remote consultations.

We strongly believe that device manufacturers must move beyond

product centric business models and use patient-oriented service

design (like a smart IoT enabled platform) to create comprehensive

healthcare experiences.

Bosch Healthcare leverages its precision engineering and state-of-

the-art technology in Internet of Things (IoT), sensor technology and

Social Mobility Analytics Cloud (SMAC), to promote innovation in a

patient-centric healthcare delivery model. This is exactly how we have

been enabling medical device companies to transform care delivery.

We see the following three pivots that would be major tenets for this change in the medical field:1. People: With increasing consumerism, patients are at the driver’s

seat, and will be in the center of the entire healthcare ecosystem.

2. Data: Data will be one of the strongest buzzwords in the

years to come. Electronic Health Records (EHRs) will become

Comprehensive Health Records (CHRs) to accommodate data

from many sources including remote health care data and social

determinants of healthcare.

3. Technology: Emerging technologies like AI, cognitive, machine

learning will unlock the value of data, and open source

technologies like block chain (distributed ledger technology), will

help to address the challenges related to security and privacy.

The last point – ‘technology’ is at the heart of change right now.

With the advancement of technology there is a conscious demand

for better engagement and quality services in the healthcare sector.

Customers anticipate intuitive, smart interactions as opposed to the

traditional models of care delivery. Care delivery is also undergoing

changes with the primary focus being on providing value-based

services. With the help of emerging technologies, there is an

increasing shift from traditional to ‘smart’.

In India especially, technology can play a key enabler in improving the

healthcare scenario in the rural sector. We are already working on rural

healthcare delivery solutions to address the critical needs of the same.

I would like to highlight a few of the most pressing issues we are dealing with:

Lack of trained medical professionals at Point of Care

Lack of early diagnosis that helps avoid medical complications

Affordable and accessible healthcare that does not impact the

daily livelihood

With technology advancements, we can also continuously monitor

and flag critical alerts, and thus ensure pro-active, quality care is

provided at the right time, thereby reducing the pressure on the

current clinical set-up. A connected health ecosystem with the

key tenets of smart, personalized, portable and virtual, can aid the

improvement in focus on preventive, diagnostics and wellness, and

reduce the load on therapeutic in the entire spectrum of care.

All appropriate investments in terms of innovation funding,

partnerships with external associations like NATHEALTH, global

research universities and other ecosystem partners, are being made.

Intellectual property in the form of Patents, as well as various thought

leadership publications like White Papers and Blogs have been

continuously generated. We have won many laurels like the Edison

award, HIMSS Asia pacific award to name a few.

We can use technology as a key enabler to promote better health, lower

costs and ensure last mile connectivity. Bosch technology is designed to

fascinate, as well as to improve quality of life. Bosch believes that we can

make a difference to the field of Healthcare in India.

With input from Mr Guruprasad, VP,

Healthcare domain, Robert Bosch

Engineering and Business Solutions.

26 FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE 27

technologies are unable to treat genetic,

debilitating lifestyle, age-related, auto-

immune disorders, cancers etc.; that

afflict the society. Dr. Mahajan brings new

dimensions in the management of diseases

from ‘Pills to Cells.’ He believes that cell-

based therapy holds immense potential

in treatment of several chronic and life-

threatening diseases. Dr. Mahajan’s vision

is to replace organ transplantation with

his concept of autologous cell transplant

using the body as a bioreactor. He aims to

address the challenges currently associated

with organ transplantation namely limited

donors/source of organs and graft vs.

host disease, by capitalizing on the varied

properties of cells and growth factors in our

body.

Dr. Mahajan has collaborated academically

at national and international levels with

universities in Maharashtra (MUHS), Ohio

(Ohio State University) and Indianapolis

(Indiana University) for clinical trials. He

has been honored with many international

awards. He has also published a patent

for treatment of Avascular Necrosis using

Regenerative Medicine approach and

National patents for Avascular Necrosis,

Ankylosing Spondylitis, Ischemic-tolerance

Mesenchymal Stem Cell treatment,

Technology for isolation of dental pulp stem

cells. He has many research publications to

his credit and has ongoing clinical trials

exploring new technologies like Tissue

Nano Transfection, Cancer Immunotherapy

(NK Cells), PRP lysate and many more.

MAVERICK APPROACH: In 2011, Dr. Mahajan decided to take a

leap in the field of regenerative medicine

and established his brainchild StemRx

BioScience Solutions Pvt. Ltd. a top-notch

cGMP grade facility. StemRx is the first of

its’ kind in Asia for immunotherapy using

Prodigy system. StemRx today has emerged

as a leader in clinical quality and innovation

in the healthcare industry, redefining the

progression of medical science. StemRx

has devised treatment protocols for 6500+

patients till date. StemRx works with the

aim of simplifying research in addition to

ensuring cost effectiveness and breaking

the barriers of conventional treatments.

LEGEND OF LIVING DRUGDr. Mahajan brings new dimensions in the management of diseases from ‘Pills to Cells.’ He believes that cell-based therapy holds immense potential in treatment of several chronic and life-threatening diseases.

Rapid progress in technology and better understanding of human biology has led to

the emergence of innovations to unmet needs and failing conventional medicine.

The present century is witnessing breakthrough developments, with Regenerative

Medicine (RM) being at the forefront. This field focuses on the replacement and regeneration

of tissues or organs by utilizing the potential of endogenous repair mechanisms of the

body. Moving beyond the scope of conventional medicine, RM is the intersection of

various technological approaches including gene therapy, cell-based therapy, and tissue

engineering and others.

A FORMIDABLE INTELLECTUAL:Counted as one among the leading regenerative medicine experts in India, Dr. Pradeep V.

Mahajan is an internationally acclaimed general surgeon, urologist as well as an academician

and regenerative medicine researcher by profession for over three decades.

He believes in what Albert Einstein said, “We cannot solve the problem by using the same

kind of thinking we used when we created them.”, when it comes to challenges in current

medical systems and treatments.

Dr. Mahajan is of the opinion that science is dynamic, and one must continuously

strive to find solutions to address unsolved problems. He feels that the conventional

Dr. Pradeep Mahajan believes in “Repair without cuts” by offering

non-invasive therapies and viable options for 80+ life threatening

conditions. A vision turned reality of innovations in the dynamics

of medicine is propelling him to become a part of the medical

revolution of the 21st century that is setting new standards every

day in cell-based research and regenerative medicine.

StemRx BioScience Solutions Pvt. Ltd. envisions to create a patient-

centric tertiary healthcare experience focusing on non-intrusive

quality care by utilizing cutting edge technologies of regenerative

medicine. With patients coming from all around the globe, StemRx

is focused on providing a delightful and ecstatic experience to the

patients. His never-ending passion and the dedicated effort has

helped StemRx in achieving milestones since 2011.

AWE-INSPIRING OBJECTIVE: Dr. Pradeep Mahajan aims to promote cell-based therapy at a global

level, while also ensuring that the technology is accessible to the

masses. When asked about his ideology behind StemRx, he said, “You

carry your own repairing kits within yourself’. Soon, I believe that

there will be a day when treatments will comprise of Cells and not

Pills!” Dr. Mahajan not only believes in offering medical assistance to

those in need but also likes to share his knowledge pearls with the

young generation of the country. He firmly believes that if harnessed,

regenerative medicine is the living drug molecule that could

revolutionize the world of healthcare.

CURE FOR TOMORROW: Visualizing the changing dynamics of medicine, Dr Pradeep V

Mahajan believes that when you look back at the 20th century, the

greatest scientific achievements which can change human life will

not be from the field of space science or computer science but will

be from regenerative medicine. Dr. Mahajan strives towards finding

scientific breakthrough technologies that was never imagined.

The ongoing discovery of cell-based therapy has given rise to a

new alternative treatment protocol. Regenerative medicine has

shifted our clinical goal from repair to regeneration. Regenerative

medicine is truly revolutionizing the field of medicine through

autologous therapy using cells and growth factors to address the

root cause of the disease. With this goal, the concept has expanded

to a variety of other applications such as Tissue engineering and

Genetic medicine. Future goals should be towards use of stem cell

rich blood from the umbilical cord as a key element in achieving

regeneration. These clinical goals can provide long-term cures to

previously untreatable injuries and diseases.

We cannot solve the problem by using

the same kind of thinking we used

when we created them.

INNOVATIVE HEADWAYS:Regenerative Medicine is breaking the

barriers for treatment of diseases for a

variety of reasons- it leads to repopulation

of healthy cell pools, regenerates tissues,

boosts immunity, rejuvenates organs, and

improves the quality of life. Regenerative

Medicine exclusively supports all avenues

that lead to the replacement or regeneration

of human cells, tissue or organs, to restore

or establish normal function. The sector is

rapidly evolving and multidisciplinary in

nature. The field of regenerative medicine is

promising and can be explored to augment

organ function, repair, and even regenerate

by utilizing the body’s own repair and healing

mechanisms. One may say that the

body is converted into a natural

reactor to heal itself.

Dr. P. V. MahajanUrosurgeon and Regenerative Medicine Researcher

28 FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE 2928 FORBES INDIA MARQUEE . LEADERS

Care24 was started in 2014 by IIT Kanpur alumni Vipin Pathak and

Garima Tripathi. Starting as a personal need to get better care for

their own parents, the team decided to start reliable medical services

at home in Mumbai and expand to other cities. The need for a nurse

for simple blood pressure check or injections is difficult for children

who either have to take off from work to visit hospitals or rely on

local agencies. The local agencies have no reliability or quality check

on services. Care24 started solving this basic need of a qualified

medical professional who could provide standard services at home.

Research has proven that patients can recover faster (20-30%) due

to higher comfort at home and reduce hospital readmission by 27%.

Background verification, medical and soft skill training and a very

strong technology foundation has helped us deliver quality care at

home. We have been able to significantly increase care providers

income with more work and higher salaries.

The homecare segment is highly fragmented in India unlike US, Japan

and others where the government or insurance cover has made it is

an organized and regulated industry. World home healthcare market

is expected to reach $349.8 billion by 2020 from $227.5 billion in

2015 growing 9% annually. In India the market size is roughly $4

billion with ancillary markets about $20 billion. With increasing

nuclear families and growing elderly population in metros, there is a

huge gap between the demand and available solutions.

We are determined to bring quality and standardization in this

sector. Care24 now serves 1200 patients every day. Today, we have

over 2000 active medical caregivers and the company has helped

over 50,000 families recuperate in the comfort of their homes.

The quality of delivered services has made us the trusted brand for

home healthcare both for the customers and caregivers. We take

pride in the fact that more than 70% of our caregivers are hired

through referral program showing high levels of trust placed in us

by our caregivers. Similarly 50% of our customer come from referral

from families we have served in past. The biggest challenge that a

customer faces today is lack of reliable care partner when they need

the most. We ensure guaranteed service and faster resolution using

technology and trained staff.

Through our technology and supervision every patient service and

recovery is monitored from timely start, feedback, recovery, query

resolution from the consumer, patients and caregivers.

We have achieved this trust by investing in upskilling the caregiver

and through effective use of technology. Customer and caregiver

have mobile application to keep track of the services.

Every caregiver also gets a bank account and this has brought

financial inclusion to more than 5000 providers who were left out of

the digital economy.

The inhouse technology makes the unit economics profitable and

Care24 is the only homecare company in India that will be profitable

Care24: Reliable Care at Home

Care24 is one of the leading home healthcare company and

envisions to become the biggest platform for all health

services at home. Strongly built on technology and heavily

invested in quality and training processes, we make home-healthcare

reliable, accessible and affordable for one and all. Our services are

currently available in Mumbai and NCR region. We aim to start

the services in 5 more cities this year. We offer patient services to

multiple acute and chronic conditions cases of Post-Hospitalization,

Stroke, Cardiac, Neuro, Ortho, Elderly bedridden, Dementia, Cancer

etc. The core services offered are Medical Nursing, Physiotherapy,

Attendants, ICU & Step down at Home.

soon. The processes and systems developed are poised to take 10

more cities without adding a lot of overheads and hence providing

affordable care to more families.

Care24 is looking to expand its services to five more cities in the next 12 months.

The prospective cities are Bengaluru, Chennai, Hyderabad, Kolkata

and Pune. The elderly population is expected to grow to 325 million

from current 100 million. The need for condition management

for chronic diseases, cardiovascular and cancer is exponentially

increasing and the in-home healthcare for the aged is becoming

a necessity. Insurance, Hospitals, Pharma and other healthcare

players are keen to partner with Homecare companies to reduce

LOS (length of stay) in hospital, increase hospital capacity to service

critical patients and improve overall health of patients.

Care24 is also looking at specific areas such as specialised medical

delivery, providing complete care, diagnostic and medical

equipment services. We aim to serve 3000 patients per day from

the current 1,200 per day over the 12 months.

The biggest challenge in homecare is the lack of trained staff.

The company plans to train 10000 healthcare professionals for

elderly care and specialised treatments such as cancer care and

neurological care in association with specialised agencies such as

NSDC, AIIMS and Tata Memorial, among others. We believe that

skilling and training is the only way forward for creating the right

kind of talent pool for the healthcare industry. With the use of our

large network, we aim to lead in this market by creating technology

and supply pool that can serve the industry in the coming decade.

Care24 platform has helped attendants and nurses build their own

homes, pay for their kids education and get treatment for their loved

ones. The 360 degree approach in taking care of our caregivers has

enabled us to provide the best care to the patients.

Healthcare is about long term investments and consistent efforts.

Our continuous effort in working with customer’s requirements,

creating new service lines and empowering supply financially and

technologically has helped us to become the Trusted brand in Home

care. With the addition of new cities, disease specific offerings and

more affordable products and services across different verticals, our

long term goal is to serve 50,000 patients/day on the platform for all

of their healthcare needs.

Garima Tripathi, Co-Founder & COO

Vipin Pathak, Co Founder & CEO

Care24 is solving the basic medical need for quali ed medical professional providing standardized services at home.

The prospective cities

are Bengaluru, Chennai,

Hyderabad, Kolkata

and Pune. The elderly

population is expected

to grow to 325 million

from current 100 million.

The need for condition

management for chronic

diseases, cardiovascular

and cancer is exponentially

increasing and the in-home

healthcare for the aged is

becoming a necessity.

30 FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE

At Suburban Diagnostics, we aim to “inspire people to live healthy” by delivering a

“wow experience” based on “precision and care.” We aspire “to be the most admired

diagnostic company in the world.”

Healthcare costs in India are largely out-of-pocket. Hence, healthcare is extremely reactive. Our

objective is to change this philosophy. “Don’t do a test only when you fall ill, do a test not to fall

ill” is the mantra we want to evangelize. Today, patients come to us only when they fall ill and

if a doctor has recommended some tests; we want to change this habit of the patient so that

they can come to us to remain healthy.

“You can’t pour from an empty cup” – for someone to be effective with anything in life, good

health is at its core. Look after yourself so that you can look after everything else.

Our core pillars have been to use the best technology with the best team to deliver the highest

degree of customer convenience. Providing comprehensive diagnostic services for customer

convenience allowed us to bring a wide range of Pathology, Radiology and Cardiology services

along with Preventive Health Check-ups under one roof. To ensure precision and quality, we are

accredited by NABL (National Accreditation Board for Testing and Calibration Laboratories) and

CAP (College of American Pathologists). Data shows that less than 1% of the total laboratories

are accredited by NABL in India. Suburban Diagnostics has also established two Centers of

Excellence in Medical Diagnostics – one for women’s health and another for infectious diseases.

Healthcare in India is becoming increasingly transactional. The purpose of adding value and

impacting medical outcome seems to be lost. While the country looks at improving the

economic indices, the health indices are not moving in sync. We have less than one doctor and

less than one hospital bed per one lakh population. The gap in skilled manpower for delivering

quality healthcare is also widening. The disease burden is rapidly shifting to a predominantly

non-communicable disease burden. Yet common infections continue to challenge the people.

Our objective is to use the latest technology coupled with human care to detect conditions

early, at a stage where they can be treated in the OPD, where interventions can bring about

cure, reversal or arrest of the disease.

This became a great learning for the team at Suburban Diagnostics and it has embarked on

a mission to reduce the growing burden of diseases in the country. This campaign has been

called #UnburdenYourHealth where we encourage people to become proactive about their

health (physical, mental, emotional). On the other hand, Suburban Diagnostics is also working

closely with clinicians to offer early and accurate diagnosis of diseases and help in reducing

the overall burden of disease in the country. This partnership with clinicians has been called

#UnburdenHealthcare.

As a part of these campaigns, we focus on infection control to bring down the incidence of

drug resistance, women’s health to improve maternal and child outcomes, non-communicable

diseases to reduce the impact of diabetes and heart disease, to improve bone health and to

detect cancers early.

Acknowledging the skilled manpower gap, Suburban Diagnostics has established a wholly

owned Paramedical Training Institute – SCOPE (Suburban College of Paramedical Education),

where people can get the necessary skills and expertise in modern technology.

Inspire People To Live HealthyHealthcare costs in India are largely out-of-pocket. Hence, healthcare is extremely reactive. Our objective is to change this philosophy.

Dr. Sanjay Arora, the

Managing Director of

Suburban Diagnostics and

his wife Anju commenced

their professional journey

by establishing Suburban

Diagnostics in 1994. The

intention was to bring

diagnostic expertise

and high quality care to

doctors and patients.

Today, in our 25th year,

our network is spread

over 150 customer touch

points across Mumbai,

Pune, Nagpur and Goa.

“Don’t do a test only

when you fall ill, do

a test not to fall ill” is

the mantra we want

to evangelize.

Dr. Sanjay AroraMD, Suburban Diagnostics